Quarterly report pursuant to Section 13 or 15(d)

Stockholders' Equity - Additional Information (Detail)

v3.24.1.1.u2
Stockholders' Equity - Additional Information (Detail) - shares
 3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Class of Stock [Line Items]    
Common stock issued in connection with warrant exercises 206,957 206,957
Common Stock [Member] | Pandologic Ltd [Member]    
Class of Stock [Line Items]    
Business acquisition, shares issued or issuable   135,800
Common Stock and Employee Stock Purchase Plan [Member]    
Class of Stock [Line Items]    
Shares issued in connection with stock option exercise   355,790